El interés en corto de Elicio Therapeutics da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Elicio Therapeutics. Los datos de interés en corto se actualizan cada dos semanas.

Elicio Therapeutics (NASDAQ:ELTX) Bolsa, Informe de interés en corto

Elicio Therapeutics

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ATPC

BDMD

CGBS

CRKN

DWTX

New Oriental Education & Technology Group

ELTX

EONR

FFWM

GOEV

IROQ

ORKT

RSKD

RYAM

SWKH

TMCI

TPET

TTGT

VATE

Descubre las acciones que lideran el premercado con sorprendentes subidas y caídas. INNOVATE y más protagonistas hoy.

Las acciones de INNOVATE (VATE) cotizan un 19% más alto; 20 acciones que se mueven en el premercado de EE.UU.

ALVO

BBGI

BCAX

FOXO

ISPC

JBHT

LYTS

MDXG

NATR

NUKK

OFIX

TXNM

VIAV

WILC

Explora los mayores ganadores y perdedores en las operaciones previas al mercado. Descubre qué impulsó estos movimientos destacados.

Las acciones de Versus Systems (VS) aumentan un 71%; 20 acciones que se mueven en el premercado de EE.UU.

Elicio Therapeutics Inc

US Foods Hldg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USFD#NYSE">USFD</a>) has outperformed the market over the past 5 years by 17.53% on an annualized basis producing an average annual return of 32.55%. Currently, US Foods Hldg has a market capitalization of $17.33 billion. 
Buying $1000 In USFD: If an investor had bought $1000 of USFD stock 5 years ago, it would be worth $3,907.86 today based on a price of $74.91 for USFD at the time of writing.
<h3>US Foods Hldg's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747323016_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

USFD

Here's How Much You Would Have Made Owning US Foods Hldg Stock In The Last 5 Years

Cantor Fitzgerald analyst Ross Osborn reiterates Lucid Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUCD#NASDAQ">LUCD</a>) with a Overweight and maintains $2 price target.

Price Target

Reiteration

Analyst Ratings

LUCD

Cantor Fitzgerald Reiterates Overweight on Lucid Diagnostics, Maintains $2 Price Target

Cantor Fitzgerald analyst Kristen Kluska upgrades Fulcrum Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FULC#NASDAQ">FULC</a>) from Neutral to Overweight and announces $10 price target.

Upgrades

FULC

Cantor Fitzgerald Upgrades Fulcrum Therapeutics to Overweight, Announces $10 Price Target

WIIM

CNEY

CN Energy Group shares are trading lower after the company reported a 1-for-25 reverse stock split.

Reddit Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NASDAQ">RDDT</a>) shares fell 9.4% to $113.55 on Thursday, pulling back after a recent rally that had lifted the stock more than 25% over the past month. The decline follows a 9.2% jump on Wednesday, fueled by the company's strong <a href="https://www.benzinga.com/general/social-media/25/05/45178546/reddit-executives-see-strong-growth-in-q2-and-beyond">first-quarter earnings</a> and upbeat outlook.
What To Know: Reddit recently posted first-quarter earnings of 13 cents per share, beating consensus estimates of 2 cents. Revenue hit $392.36 million, up from $242.96 million a year ago, driven by a 61% surge in ad revenue and a 31% increase in daily active users to 108.1 million. 
Net income <a href="https://www.benzinga.com/general/social-media/25/05/45178546/reddit-executives-see-strong-growth-in-q2-and-beyond">reached $26.2 million</a>, reversing a $575.1 million loss a year prior. Operating cash flow rose to $127.6 million, while gross margin improved to 90.5%.
Read Also: <a href="https://www.benzinga.com/general/sports/25/05/45424475/foot-locker-stock-soars-on-potential-dicks-sporting-goods-deal-report">Foot Locker Stock Soars On Potential Dick&#8217;s Sporting Goods Deal: Report</a>
CEO Steve Huffman touted weekly active users <a href="https://www.benzinga.com/general/social-media/25/05/45151798/reddit-stock-soars-after-better-than-expected-q1-daily-active-uniques-up-31-ad-revenue-up-61-and-more">exceeding 400 million</a>, and Reddit guided second-quarter revenue between $410 million and $430 million. Analysts responded positively: Seaport upgraded Reddit to Buy, Needham and JP Morgan raised their price targets, and consensus remains optimistic on long-term growth.
What Else: Meanwhile, the Kids Online Safety Act was <a href="https://www.theverge.com/news/666729/kids-online-safety-act-reintroduced">reintroduced</a> in the Senate this week. The bill would impose new safety requirements on platforms used by minors and has drawn both support and criticism, with tech firms like Apple Inc backing the measure and civil liberties groups voicing concern over potential censorship.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45439079/powell-signals-fed-may-shift-its-inflation-strategy-after-5-year-economic-shake-up">Powell Signals Fed May Shift Inflation Strategy After 5 Years Of Economic Upheaval</a>
<h2 class="wp-block-heading">How To Buy RDDT Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Reddit&#8217;s case, it is in the Communication Services sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, RDDT has a 52-week high of $230.41 and a 52-week low of $49.13.

RDDT

Reddit (RDDT) Stock Is Down 9% Thursday: What's Going On?

Telsey Advisory Group analyst Dana Telsey maintains Birkenstock Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BIRK#NYSE">BIRK</a>) with a Outperform and maintains $70 price target.

BIRK

Telsey Advisory Group Maintains Outperform on Birkenstock Holding, Maintains $70 Price Target

Click Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIK#NASDAQ">CLIK</a>) shares are trading higher after the company announced it signed <a href="https://www.benzinga.com//node/45432200">a cooperation agreement</a> with Flash Mutal Technology.
What To Know: Click will work with Flash Mutual to jointly promote 24-hour instant device services for senior citizens in Hong Kong.
Flash Mutal, a company under Tencent's Sustainable Social Value initiatives, is a national high-tech enterprise headquartered in Guangdong, China. It aims to provide digital solutions to the elderly, students and the disabled.
The devices leverage AI to &#8220;offer round-the-clock smart monitoring for senior citizens to enhance their safety and to provide timely assistance when necessary.&#8221;
Click expects the partnership, together with the recently entered government-sponsored Community Care Service Voucher scheme for the elderly, to generate significant cross-selling synergies and boost revenue.
The stock is trading on higher-than-normal session volume at 349.71 million shares. The company&#8217;s average session volume over the past 100 days is 2.42 million shares, per data from <a href="https://www.benzinga.com/pro/login">Benzinga Pro</a>.
Related Link: <a href="https://www.benzinga.com/news/earnings/25/05/45436534/walmart-doesnt-alter-annual-outlook-yet-ceo-says-all-tariffs-create-cost-pressures-but-china-has-biggest-impact">Walmart Doesn&#8217;t Alter Annual Outlook Yet, CEO Says &#8216;All Tariffs Create Cost Pressures But China Has Biggest Impact&#8217;</a>
CLIK Price Action: At the time of publication, Click shares are trading 163.1% higher at 73 cents, according to data from <a href="https://www.benzinga.com/pro/login">Benzinga Pro.</a>
Image:

CLIK

Click Stock Is Soaring Thursday: What's Going On?

CRWV

CoreWeave shares are trading higher after the company entered in to an additional agreement with OpenAI. OpenAI has committed to pay the company up to $4.0 billion through April 2029 related to this agreement.

TOON

Kartoon Studios shares are trading higher after the company reported a year-over-year increase in Q1 financial results.

Cantor Fitzgerald analyst Jennifer Kim reiterates Belite Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLTE#NASDAQ">BLTE</a>) from Overweight to Overweight.

BLTE

Cantor Fitzgerald Reiterates Overweight on Belite Bioto Overweight

BWS Financial analyst Hamed Khorsand maintains Hawkins (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWKN#NASDAQ">HWKN</a>) with a Buy and maintains $160 price target.

HWKN

BWS Financial Maintains Buy on Hawkins, Maintains $160 Price Target

ZEEKR Intelligent Technology Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZK#NYSE">ZK</a>)&nbsp;reported <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/n45427547/zeekr-group-reports-first-quarter-2025-unaudited-financial-results" rel="noreferrer noopener">fiscal&nbsp;first-quarter</a> results on Thursday. The company reported quarterly revenue of 22.02 billion&nbsp;Chinese yuan, representing&nbsp;an increase of&nbsp;1.1% year-on-year.
In U.S. dollars, revenue of $3.03 billion missed the analyst <a href="https://www.benzinga.com/earnings">consensus estimate of $3.90 billion</a>.
The&nbsp;Zeekr brand delivered 41,403 vehicles, an increase of 25.2%. Meanwhile, the Lynk &amp; Co brand delivered 72,608 vehicles, recording a growth of 18.9%, with 52.4% of deliveries coming from NEV models.
The premium electric vehicle company&#8217;s adjusted net loss per ADS was 2.33 Chinese yuan. In U.S. dollar terms, the company reported adjusted net loss per ADS of 32 cents.
Also Read: <a href="https://www.benzinga.com/25/03/44492590/alibaba-and-bmw-team-up-to-bring-ai-powered-smart-assistant-to-next-gen-cars-in-china" target="_blank" rel="noreferrer noopener">Alibaba, BMW Team Up To Bring AI-Powered Smart Assistant In Next-Gen China Cars</a>
Vehicle sales&nbsp;were&nbsp;19.1 billion&nbsp;Chinese yuan&nbsp;($2.63 billion) for the quarter, representing an increase of&nbsp;16.1%&nbsp;Y/Y driven by the increase in new model delivery volume, partially offset by the lower average selling price due to changes in product mix and pricing strategy.
The vehicle margin was&nbsp;16.5%, up from&nbsp;13.1%&nbsp;in the prior year quarter, driven by sustained cost-saving initiatives.
Revenues from other sales and services&nbsp;declined 45.2% Y/Y&nbsp;to $403 million for the quarter, mainly due to the decreased sales volume and unit price of battery packs and electric drives.&nbsp;
The gross margin expanded to&nbsp;19.1% for the quarter from&nbsp;16.3%&nbsp;a year ago. Adjusted net loss was $88 million for the quarter, down by 66.5%.
As of&nbsp;March 31, 2025, cash and cash equivalents and restricted cash&nbsp;stood at 9.9 billion Chinese yuan ($1.36 billion).
Jing Yuan, CFO, said, &#8220;In the first quarter of 2025, enhanced platform synergies and disciplined supply chain management drove record profitability, with our overall vehicle margin reaching 16.5% and the Zeekr brand&#8217;s margin rising to an unprecedented 21.2%.&#8221;
Price Action: ZK shares are trading lower 1.04% to $28.48 at the last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45238222/teslas-future-hinges-on-china-fsd-analyst-says" target="_blank" rel="noreferrer noopener">Tesla&#8217;s Future Hinges On China FSD: Goldman Sachs</a></li>
</ul>
Image by aapsky via Shutterstock

Asia

Earnings

Tech

Zeekr Vehicle Sales Jump 25%, Cost Cuts Drive Record Margins

Archer Aviation Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACHR#NYSE">ACHR</a>) shares are moving higher and trending on Thursday. Here&#8217;s a look at <a href="https://www.benzinga.com/pressreleases/25/05/b45435097/archer-selected-as-the-official-air-taxi-provider-of-the-la28-olympic-and-paralympic-games-and-tea">what&#8217;s going on</a>.
What To Know: Archer on Thursday announced an exclusive partnership making the company the official air taxi provider of the LA28 Olympic and Paralympic Games. The company was also selected as the official air taxi provider for Team USA.
&#8220;We want to transform the way people get around Los Angeles and leave a legacy that shapes the future of transportation in America. There&#8217;s no better time to do that than during the LA28 Games,&#8221; said Adam Goldstein, CEO and founder of Archer Aviation.
Archer said it will provide its Midnight eVTOL aircraft during the games for fan and VIP transportation. The agreement also includes access to storytelling throughout NBCUniversal&#8217;s 2026 and 2028 Olympic Games coverage.
Check This Out: <a href="https://www.benzinga.com/content/45433719/joby-just-flew-two-aircraft-at-once-heres-why-it-matters">Joby Just Flew Two Aircraft at Once—Here&#8217;s Why It Matters</a>
Archer shares have surged more than 35% over the past week, boosted by the company&#8217;s quarterly results at the start of the week. The company reported a smaller-than-expected loss of 17 cents for the first quarter versus estimates for a loss of 28 cents. 
Archer said its spending for the quarter stayed within the previously guided range. The company ended the quarter with $1.03 billion in cash and cash equivalents, its highest cash position to date.
Archer also confirmed that it&#8217;s on track to deliver its first aircraft to the UAE in the coming months and said deployment is slated for sometime in 2025.
&#8220;This quarter, the team made strong progress across our civil and defense efforts as we continue to deepen our strategic partner relationships and prepare for commercialization in the UAE later this year," Goldstein said. 
ACHR Price Action: <a href="http://benzinga.com/quote/ACHR">Archer shares</a> are up about 68% over the past month and have risen approximately 220% over a one-year period. The stock is trading near its 52-week highs of $12.47 and has a momentum score of 98.89, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. Archer shares were up 2.79% at $12.16 at the time of publication Thursday. 
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45418446/this-weeks-best-short-squeeze-options-trade">This Week&#8217;s Best Short Squeeze Options Trade</a></li>
</ul>
Photo: courtesy of Archer Aviation.

ACHR

Archer Aviation Stock Has Strong Momentum: What's Driving The Action?

<a href="https://www.salesforce.com/news/stories/salesforce-signs-definitive-agreement-to-acquire-convergence-ai/#:~:text=Salesforce%20has%20signed%20a%20definitive,like%20tasks%20in%20digital%20environments">https://www.salesforce.com/news/stories/salesforce-signs-definitive-agreement-to-acquire-convergence-ai/#:~:text=Salesforce%20has%20signed%20a%20definitive,like%20tasks%20in%20digital%20environments</a>

General

Reported Earlier: "Salesforce Signs Definitive Agreement to Acquire Convergence.ai"; No Financial Terms Disclosed

Tigress Financial analyst Ivan Feinseth maintains Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) with a Buy and lowers the price target from $116 to $112.

Tigress Financial Maintains Buy on Dolby Laboratories, Lowers Price Target to $112

Cantor Fitzgerald analyst Jennifer Kim reiterates Precigen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGEN#NASDAQ">PGEN</a>) from Overweight to Overweight.

PGEN

Cantor Fitzgerald Reiterates Overweight on Precigento Overweight

INAB

IN8bio shares are trading lower. The company announced new preclinical data from its INB-619 program at the 2025 American Society of Gene & Cell Therapy Annual Meeting

RNAZ

TransCode Therapeutics shares are trading lower after the company reported worse-than-expected Q1 EPS results.

Barrington Research analyst Alexander Paris maintains ZSPACE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZSPC#NASDAQ">ZSPC</a>) with a Outperform and lowers the price target from $11 to $10.

ZSPC

Barrington Research Maintains Outperform on ZSPACE, Lowers Price Target to $10

"Enough is enough," Kevin O'Leary said on CNN's "<a href="https://www.youtube.com/watch?v=gyRXiXQlTMQ">Laura Coates Live</a>" on April 23, launching into a fiery on-air clash that ended with him demanding a staggering 400% tariff on Chinese imports. "Let's just level the playing field," he added. "The [Chinese] government cheats, steals, robs, and does not play by any rules. I don't think 125% is enough—400%!"
The "Shark Tank" investor's push for aggressive trade action sparked a heated exchange with Ross Gerber, CEO of Gerber Kawasaki Wealth &amp; Investment Management, who countered that the U.S. is "tarnishing its brand globally" with its current tariff strategy.
Don't Miss:
<ul class="wp-block-list">
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
<li>Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.</li>
</ul>
<h2 class="wp-block-heading">Clash Over Costs, Trade, And National Identity</h2>
During the CNN debate, O'Leary insisted that the U.S. needs to show resolve. "Have some backbone, my friend. Show some strength. That is the American brand. That is the American entrepreneur," he told Gerber, whom he branded "weak" for opposing stronger tariffs. "You're weak!"
Gerber fired back: "This isn't just about China. You're Canadian. And the Canadians couldn't be more angry at us. We're about to see a dramatic increase in costs across America. Americans haven't had things disappearing from the shelves since COVID."
O'Leary clarified: "First of all, let's set the record straight. I have multiple nationalities. My whole family is American. Now be strong and get ready for the fight of your life."
He emphasized the need to retaliate against intellectual property violations: "To settle this issue with China. Cheating, stealing, ripping off American IP. Enough is enough."
Trending: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a>
The interview came on the heels of President Donald Trump's April announcement that tariffs on Chinese goods were being increased to 145%. China hit back with its own 125% levy on U.S. imports, escalating the trade conflict further.
According to <a href="https://moneyweek.com/economy/global-economy/us-china-trade-decoupling">MoneyWeek</a>, the tariff battle is already triggering ripple effects—disrupting global supply chains, shuttering Chinese factories, and boosting U.S. consumer prices. <a href="https://www.rfa.org/english/china/2025/04/29/china-us-tariff-protests-workers-wages/">Radio Free Asia</a> reported that protests erupted across China in May, reflecting growing unrest over surging inflation and factory layoffs.
The economic toll on the U.S. is also mounting. A recent <a href="https://budgetlab.yale.edu/research/where-we-stand-fiscal-economic-and-distributional-effects-all-us-tariffs-enacted-2025-through-april">Yale Budget Lab study</a> showed that tariffs implemented in 2025 have led to a 2.3% spike in consumer prices—amounting to an average $3,800 loss per household. As per <a href="https://www.cnbc.com/2025/04/30/gdp-q1-2025-.html">CNBC</a>, the U.S. GDP shrank by 0.3% in the first quarter.
Citadel CEO and a major Republican donor Ken Griffin issued a critical response on April 23 during Semafor's World Economy Summit, Griffin said Trump's tariffs had left the country "20% poorer in four weeks," arguing that the impact on the U.S. brand may take years to undo.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/mark-cubans-advice-for-lotto-winners">Many are surprised by Mark Cuban's advice for lotto winners: Cash or annuity?</a></li>
<li>Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000.</a></li>
</ul>
Image: Shutterstock

Personal Finance

'Enough Is Enough': Kevin O'Leary Pushes For 400% Tariffs In CNN Debate With Ross Gerber – 'Get Ready For The Fight Of Your Life'

Health Care

Press Releases

Elicio Therapeutics Presents Updated Translational Data from ELI-002 Phase 1 AMPLIFY-7P Study at the Society for Immunotherapy of Cancer ("SITC") 2024 Annual Meeting

Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment

Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024

Elicio Therapeutics Reaches Alignment with FDA on ELI-002 Registrational Strategy

Financing

Elicio Therapeutics Announces $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Management

Elicio Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Strategy and Financial Officer

Elicio Therapeutics Reports 2024 Financial Results and Provides Corporate Updates

Elicio Therapeutics Reports Inducement Grant to New Chief Strategy and Financial Officer and Other New Hires

Elicio Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Updates

Achieve Life Sciences, Inc. - Common Shares

Achieve Life Sciences

Adagene Inc. - ADS, each representing 1.25 ordinary shares

Adagene

Anixa Biosciences

Assembly Biosciences, Inc. - Common Stock

Assembly Biosciences

Coherus BioSciences

Climb Bio

Corbus Pharmaceuticals Holdings, Inc. - Common Stock

Corbus Pharmaceuticals

Caribou Biosciences

Galectin Therapeutics Inc. - Common Stock

Galectin Therapeutics

Genelux

Genenta Science S.p.A. - American Depositary Shares

Genenta Science

Immunic

Inozyme Pharma

Kyverna Therapeutics, Inc. - Common Stock

Kyverna Therapeutics

Lexeo Therapeutics

OncoCyte

Sera Prognostics, Inc. - Class A Common Stock

Sera Prognostics

Senti Biosciences

Instil Bio

Vaxart

Whitehawk Therapeutics, Inc. - Common Stock

Whitehawk Therapeutics

Longevity Health Holdings, Inc. - Common Stock

Longevity Health Holdings

XBiotech

Zentalis Pharmaceuticals, Inc. - common stock

Zentalis Pharma

Zura Bio Limited - Class A Ordinary shares

Zura Bio

HC Wainwright & Co.

Jones Trading

Screenshot 2024-06-07 at 5.22.00 PM

Biotech

Elicio Therapeutics Unveils Promising Phase 1a Data For ELI-002 7P In mKRAS Tumors

Screenshot 2024-04-10 at 5.39.01 PM

Elicio Therapeutics (NASDAQ: ELTX) Makes Strides In Growing Cancer Vaccination Industry

Screenshot 2024-04-04 at 5.26.54 PM

Unlocking The Power Of Immunotherapy: Elicio Therapeutics&#39; (NASDAQ: ELTX) Novel AMP Platform

Comments

Elicio Therapeutics

Interés en corto

Elicio Therapeutics (NASDAQ:ELTX) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL